A recent report published by
Infinium Global Research on cancer vaccines market provides in-depth analysis
of segments and sub-segments in global as well as regional markets of cancer
vaccines market. The study also highlights the impact of drivers, restraints
and macro indicators on the global and regional markets of cancer vaccines over
the short term as well as long term. The report is a comprehensive presentation
of trends, forecast and dollar values of global cancer vaccines market.
According to report, the global cancer vaccines market is projected to grow at a
CAGR of 17.8% over the forecast period of 2018 - 2024.
The report on global cancer
vaccines market covers segments such as technology, type, indication, and end
user. The technology segments include whole cell cancer vaccine, dendritic
cells cancer vaccines, antigen/adjuvant cancer vaccines, recombinant cancer
vaccines, and viral vector & DNA cancer vaccines. On the basis of type, the
global cancer vaccines market is categorized into preventive cancer vaccines
and therapeutic cancer vaccines. Furthermore, on the basis of indication the
cancer vaccines market is segmented as prostate cancer, cervical cancer, and
others. On the basis of end user the cancer vaccines market is segmented as adult
vaccines and pediatric vaccine.
The report provides regional
analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section, the key trends and market size for each
geography are provided over the period of 2016 – 2024. The countries covered in
the North America region include the U.S., Canada, and Mexico; while
Asia-Pacific includes China, Japan, India, South Korea, and Malaysia among
others. The U.S. drives the growth in the North America region as it is the
largest market in the region. The Asia-pacific region offers a substantial
potential for the market growth owing to rapid growth in markets such as India
and China. The APAC region is projected to experience growth at a CAGR of
x.x% over the period of 2018 - 2024.
The report provides profiles of
the companies in the global cancer vaccines market such as GlaxoSmithKline Plc, Aduro BioTech Inc.,
Astellas Pharma Inc., Merck & Co., Inc., CSL Limited, Sanpower Group,
Sanofi Pasteur, Pfizer Inc, Serum Institute of India Pvt. Ltd., and Others.
The report provides deep insights
on demand forecasts, market trends, and micro and macro indicators. In addition,
this report provides insights into the factors that are driving and restraining the
global cancer vaccines market. Moreover, IGR-Growth Matrix analysis given in
the report brings an insight into the investment areas that existing or new
market players can consider. The report provides insights into the market using
analytical tools such as Porter’s five forces analysis and DRO analysis of cancer
Moreover, the study highlights current market
trends and provides forecast from 2018 to 2024. We also have highlighted future
trends in the cancer vaccines market that will impact the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Additionally, the analysis highlights the rise and fall in the market shares of the
key players in the market. This report will help manufacturers, suppliers, and
distributors of the cancer vaccines market to understand the present and future
trends in this market and formulate their strategies accordingly.